Dissertation > Excellent graduate degree dissertation topics show

The Interference Effect of Wild Apricot and Extracts Against Experimental Animal with Hhperlipidemia and Nonalcoholic Fatty Liver

Author: ZhangHua
Tutor: WangYing
School: Xinjiang Agricultural University
Course: Biochemistry and Molecular Biology
Keywords: Hyperlipidemia Nonalcoholic Fatty Liver Prunus armeniaca L.
CLC: R285.5
Type: Master's thesis
Year: 2011
Downloads: 78
Quote: 1
Read: Download Dissertation

Abstract


Objective①To establish an animal model of hyperlipidemia, which was needed to be stable, reliable and easily repeated. To investigate the effect of FWA upon blood lipid and protecting livers of hyperlipidemia mice.②To develop the best extraction technology of effective constituent (total flavonoids and organic acids) from wild apricot (Prunus armeniaca L.) by ultrasonic sound and establish a determination method.③To study the protective effect of wild apricot extracts by ultrasound (WAEU) against experimental hyperlipidemia and nonalcoholic fatty liver and its possible mechanisms.Methods①The mice model of hyperlipidemia was fast established by intragastric administration emulsion. The hyperlipidemia mice were orally treated with FWA 0.2,0.3,0.4g-kg-1 per day respectively and Xuezhikang capsule 0.1g-kg-1 per day for 4 weeks. Then the mice serum contents of total cholesterol (TC), triglyceride (TG), high density lipoprotein-cholesterol (HDL-C) and liver index were measured. Low density lipoprotein-cholesterol (LDL-C) and atherosclerotic index (AI) were calculated as well. Liver tissue pathological changes were studied with the method of histology in order to observe whether FWA could protect liver of mice with hyperlipidemia.②With single factor experiment, the effect of factors on the extraction process was confirmed. With the orthogonal experimental design, the optimum conditions of the extraction were obtained. Both of them were studied through measuring the content of total flavonids. The assay was performed with the UV spectrophotometric method. The single experimental factors, such as ratio of solid to liquid, concentration of ethanol, temperature, ultrasound treating time, were studied. Then the optimum parameters were obtained by orthogonal test. The determination was done with potential titration.③Rat model with hyperlipidemia was successfully established by feeding fatty mash for 8 weeks, i.g. different doses of WAEU(0.2g-kg-1 and 0.4g-kg-1) and Xuezhikang(0.2 g-kg-1) per day for 8 weeks’ prevention. The serum lipid level, including the content of TC, TG, LDL-C and HDL-C, and the ability of antioxidation (the activities of MDA, SOD and GSH-Px) was measured. The activities of ALT and AST in serum were tested and the pathological change was observed to estimate the therapeutic effect of WAEU on nonalcoholic fatty liver induced by hyperlipidemia. The level of HL, LPL and LPS was obtained so that we could discuss the mechanism of WAEU reducing the blood lipid in hyperlipidemia rats.Results①FWA could significantly lower the liver index (p<0.001) and the serum contents of TC、TG、LDL-C and AI (p<0.01). The serum content of HDL-C was significantly higher than that in the model group (p<0.001), especially in the high dose group (p<0.001). The mice’s fat changes degree of liver steatosis was much more decreased.②With the UV spectrophotometric method, the factors which influenced the extraction rate were sorted as follows C>B>A, where A, B, C stood for the alcohol concentration, material-liquid ratio and the temperature. The optimum process of the extraction technology was the temperature 70℃, the ratio of material-liquid 1:50, the alcohol concentration 50%. The extraction rate of total flavonoids was 5.39%. The optimum parameters were the ratio of solid to liquid 1:10(g/mL), using 30%(V/V) ethanol, the temperature60℃, ultrasound treating 40min. The extraction rate of organic acids was 18.65%.③The results showed that WAEU could obviously decrease the content of TC, TG, LDL-C and the activities of ALT and AST and increase the content of HDL-C of serum in hyperlipidemia rats drenched with high fat suspension. WAEU also lowered level of MDA and raised activities of SOD and GSH-Px in liver tissue. The degree of hepatic steatosis in WAEU group was lighter than those in hyperlipidemia model group, especially the high dose group, which was close to normal essentially. WAEU played important roles in enhancing the LPL and HL activities and inhibiting activity of LPS.Conclusion①FWA indeed had the function of reducing blood lipid of hyperlipidemia mice in addition to the counteraction atherosclerosis. To some extent, FWA also had good prevention and treatment to fatty liver.②Ultrasound extraction for total flavonoids and organic acids from wild apricot had characteristics of shorter extraction time and lower cost and higher efficiency. The determination method of organic acids was simple, reproducible and suitable.③WAEU had effect on reducing serum lipid and preventing the formation of nonalcoholic fatty liver obviously, and they were dose-dependent. Maybe it had relationships with the improvement of ability of antiocidation, the activation of lipid metabolism enzyme activity and the inhibition the generation of fat.

Related Dissertations

  1. Research on the Influence of Cyclocarya Paliurus(Batal.) Iljinskaja Polysaccharide on FAS Gene Expression in Hyperlipoidemia Mice,R285.5
  2. Development of Apricot Core Collection in China,S662.2
  3. Atorvastatin in hyperlipidemic rabbits interventional postoperative inflammation and vascular endothelial function,R589.2
  4. Protective Effect of PDTC in a Rat Model of Nonalcoholic Fatty Liver Disease and the Possible Mechnaisms,R575.5
  5. The Influence of Lipitiaoganhuzhiwan on Blood Lipids and Pathological Trastructure of Aorta in Hyperlipidemia Mices,R285.5
  6. Effect of Hyperlipemia on Galactose Induced Cataracts in Rats,R589.2
  7. Phlegm stasis detoxification method hyperlipidemia and atherosclerosis the immunomodulatory the clinical research,R259
  8. Effects of Simvastatin on Apolipoprotein M in Vivo and in Vitro,R965
  9. Experimental and Clinical Research on EA Fenglong Point with Hyperlipidemia,R245
  10. The Research on Lipid-lowering Mechanism of Jin Kui Zexie Tang,R285
  11. Effects of Pioglitazone on NOS-NO and AdipoR of Aorta in Hyperlipidemia Rats,R589.2
  12. Hyperlipidemia Syndromes Distribution of Cross-sectional Survey,R259
  13. The Study of the Treatment on Non-Alcoholic Fatty Liver Withusing Baoganxiaozhi Granule by Observing the Change of the TNF-α after the Treatment,R259
  14. Study of Tiao Zhi Tang to Treat Coronary Heart Disease Stable Angina Pectoris Hyperlipemia,R259
  15. Sense of Mild Moxibustion and Hyperlipidemia Related to Clinical Efficacy Studies,R246
  16. The Evaluation of the Effective about Healthy Education and Dietary Intervention in Nonalcoholic Fatty Liver Disease,R473.5
  17. The Relationship between Expression of Nrf2 and Hepatocyte Apoptosis in Nonalcoholic Fatty Live Disease in Mice,R575.5
  18. Clinical Research on the Method of Kidney-Nourishing and Phlegm-Resolving Method Combined with Diane-35 on the Effects of Polycystic Ovary Syndrome with the High Testosterone,R711.75
  19. ZhiHeng Granule for the Treatment of Hyperlipidemia (Gan Shen Yin Xu, Tan Yu Nei Zu) Phase Ⅱ Multi-central Clinical Trials,R259
  20. Treatment of Type 2 Diabetes Mellitus Associated with Hyperlipemia by Tangzhiling Heji,R259
  21. Tiaozhi Decoction in Treating Hyperlipidemia on Plasma Lipid and Serum OX-LDL Clinical Study,R259

CLC: > Medicine, health > Chinese Medicine > Of Pharmacy > Pharmacology > Chinese medicine Experimental Pharmacology
© 2012 www.DissertationTopic.Net  Mobile